Increasing expenditure on proteomics research, rising healthcare burden of chronic diseases, and growing demand for biologics are key factors driving market growth

The global protein expression market size is expected to reach USD 6.07 Billion by 2028 at a CAGR of 13.5%, according to a latest report by Reports and Data. Rising prevalence of chronic diseases such as cancer, diabetes, arthritis, and anemia, among others across the globe and growing demand for protein therapeutics and biologics to treat these chronic diseases are key factors driving market revenue growth. Increasing availability of funding and investment in the biotechnology sector and proteomics research has enabled expression and isolation of recombination proteins on larger scale, and this is expected to further contribute to market growth over the forecast period.

Protein expression and purification are crucial in biotechnology and biochemistry research. Protein expression majorly refers to methods of protein synthesis, modification, and regulation in living organisms. The term also covers the object of study or laboratory techniques that are used to manufacture proteins. Protein production or expression is achieved by manipulation of gene expression in an organism in a way that enables expression of large amounts of recombinant genes. Protein expression systems or production systems are widely used in life sciences, biotechnology, and medicine. Increasing adoption of microfluidics to enhance protein expression experiments while simultaneously reducing costs, time, and labor and improving accuracy and performance is also expected to contribute to revenue growth of the market over the forecast period.

Get a sample of the report @

Some of the key companies operating in the global Protein Expression market are:

Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Promega Corporation, New England Biolabs, Qiagen, Takara Bio, Inc., Genscript Biotech Corporation, Oxford Expression Technologies Ltd., and Synthetic Genomics Inc., among others.

The pharma and healthcare sector is rapidly growing in the recent past and is expected to register substantial revenue share over the forecast period of 2028. Factors such as technological developments in the healthcare and pharma field, improving healthcare infrastructure and increasing healthcare expenditure are key factors boosting market growth. The market dynamics have completely changed after the outbreak of COVID-19 pandemic. Increasing prevalence of various chronic diseases, high occurrence of diabetes, cancer and cardiovascular disorders and rising number of accidents across the globe are fueling growth of the global Protein Expression market. In addition, increasing investments in research and development activities, high adoption of personalized medicines and ongoing research on drug discovery are further boosting market growth.

The report is curated using extensive primary and secondary research which is thoroughly evaluated by industry experts and professionals. Advanced analytical tools such as SWOT analysis, Porter’s Five Forces Analysis, and investment return analysis are used to obtain the report data. This data is represented through various diagrams, graphs, tables, and charts to help the reader understand the market dynamics accurately. The report also provides information about each market player, its global position, business expansion plan financial status, license agreement, and product and services portfolio.

Request a discount on the report @

For the purpose of this report, Reports and Data has segmented the global protein expression market based on expression system, product, application, end-use industry, and region:  

Expression System Outlook (Revenue, USD Billion; 2018-2028)

  • Prokaryotic Expression Systems
    • Escherichia coli Systems
    • Others
  • Mammalian Expression Systems
  • Yeast Cell Expression Systems
    • Kluyveromyces Lactis Systems
    • Saccharomyces Systems
    • Pichia Systems
    • Other Systems
  • Insect Cell Expression Systems
    • Baculovirus Expression Systems
    • Other Systems
  • Cell-free Expression Systems
  • Others

Product Outlook (Revenue, USD Billion; 2018-2028)

  • Reagents
  • Competent Cells
  • Instruments
  • Services

Application Outlook (Revenue, USD Billion; 2018-2028)

  • Therapeutic
  • Research
  • Industrial

End-use Industry Outlook (Revenue, USD Billion; 2018-2028)

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • CROs
  • Others

To know more about the report @

Regional Outlook:

  • North America (U.S., Canada, Mexico)
  • Europe (Italy, U.K., Germany, France, Rest of Europe)
  • Asia Pacific (India, China, Japan, South Korea, Australia, Rest of APAC)
  • Latin America (Chile, Brazil, Argentina, Peru, Rest of Latin America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Request a customization of the report @

Thank you for reading our research report. Kindly note that we also offer report customization as per client requirement. Contact us to know more about the customized report and our team will offer you with the best suited report as per your request.

Browse More Reports:

Desloratadine Market @

Hospice Market @

Healthcare Equipment Leasing Market @

Cell and Tissue Preservation Market @

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web:

Direct Line: +1-212-710-1370